Cargando…

GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers

During the process of tumorigenesis, inactivation of tumor suppressors is a critical step. EZH2, a histone methyltransferase, promotes cell growth and migration through catalyzing trimethylation of histone H3 at Lys 27 (H3K27me3) and plays an important role in tumorigenesis. Its expression can be co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ko, How-Wen, Lee, Heng-Huan, Huo, Longfei, Xia, Weiya, Yang, Cheng-Chieh, Hsu, Jennifer L., Li, Long-Yuan, Lai, Chien-Chen, Chan, Li-Chuan, Cheng, Chien-Chia, Labaff, Adam M., Liao, Hsin-Wei, Lim, Seung-Oe, Li, Chia-Wei, Wei, Yongkun, Nie, Lei, Yamaguchi, Hirohito, Hung, Mien-Chie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302978/ https://www.ncbi.nlm.nih.gov/pubmed/27494834 http://dx.doi.org/10.18632/oncotarget.11008

Ejemplares similares

Regulation and Role of EZH2 in Cancer
por: Yamaguchi, Hirohito, et al.
Publicado: (2014)

CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
por: Nie, Lei, et al.
Publicado: (2019)

Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
por: Nie, Lei, et al.
Publicado: (2020)

Phosphorylation of USP27X by GSK3β maintains the stability and oncogenic functions of CBX2
por: Xing, Yushu, et al.
Publicado: (2023)

EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer
por: Yamaguchi, Hirohito, et al.
Publicado: (2017)

Inhibition of GSK 3β Activity Is Associated with Excessive EZH2 Expression and Enhanced Tumour Invasion in Nasopharyngeal Carcinoma
por: Ma, Renqiang, et al.
Publicado: (2013)

EZH2-mediated H3K27me3 inhibits ACE2 expression
por: Li, Yuanyuan, et al.
Publicado: (2020)

Beyond NF-κB activation: nuclear functions of IκB kinase α
por: Huang, Wei-Chien, et al.
Publicado: (2013)

EZH2/H3K27Me3 and phosphorylated EZH2 predict chemotherapy response and prognosis in ovarian cancer
por: Sun, Si, et al.
Publicado: (2020)

An optimized protocol for PD-L1 pathological assessment with patient sample deglycosylation to improve correlation with therapeutic response
por: Wang, Ying-Nai, et al.
Publicado: (2022)

STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
por: Hsu, Jung-Mao, et al.
Publicado: (2018)

EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia
por: Li, Jiali, et al.
Publicado: (2013)

EZH2 Methyltransferase and H3K27 Methylation in Breast Cancer
por: Yoo, Kyung Hyun, et al.
Publicado: (2011)

An oncogenic Ezh2 mutation cooperates with particular genetic alterations to induce tumors in mice and redistributes H3K27 trimethylation throughout the genome
por: Souroullas, George P., et al.
Publicado: (2016)

EZH2-mediated H3K27me3 is a predictive biomarker and therapeutic target in uveal melanoma
por: Hou, Chen, et al.
Publicado: (2022)

Histone H3K27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced AKI
por: Li, Bojun, et al.
Publicado: (2023)

FBP1 knockdown decreases ovarian cancer formation and cisplatin resistance through EZH2-mediated H3K27me3
por: Xiong, Xifeng, et al.
Publicado: (2022)

Interplay of miR-137 and EZH2 contributes to the genome-wide redistribution of H3K27me3 underlying the Pb-induced memory impairment
por: Gu, Xiaozhen, et al.
Publicado: (2019)

CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition
por: Ma, Xianxiong, et al.
Publicado: (2021)

SPRY4 suppresses proliferation and induces apoptosis of colorectal cancer cells by repressing oncogene EZH2
por: Guo, Jia, et al.
Publicado: (2021)

Phosphoproteomics and Bioinformatics Analyses Reveal Key Roles of GSK-3 and AKAP4 in Mouse Sperm Capacitation
por: Syifa, Nailis, et al.
Publicado: (2020)

EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer
por: Debeb, Bisrat G, et al.
Publicado: (2014)

The Pseudogene DUXAP8 Promotes Colorectal Cancer Cell Proliferation, Invasion, and Migration by Inducing Epithelial-Mesenchymal Transition Through Interacting with EZH2 and H3K27me3
por: He, Wenjing, et al.
Publicado: (2020)

Activation of phagocytosis by immune checkpoint blockade
por: Li, Chia-Wei, et al.
Publicado: (2018)

The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells
por: Yu, Tianfu, et al.
Publicado: (2017)

EZH2-Mediated H3K27me3 Targets Transcriptional Circuits of Neuronal Differentiation
por: Buontempo, Serena, et al.
Publicado: (2022)

Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer
por: Qiu, Yufan, et al.
Publicado: (2021)

EZH2 inhibitor GSK343 inhibits sepsis-induced intestinal disorders
por: Yue, Dongyou, et al.
Publicado: (2021)

EZH2/hSULF1 axis mediates receptor tyrosine kinase signaling to shape cartilage tumor progression
por: Lin, Zong-Shin, et al.
Publicado: (2023)

Ezh2 Inhibits Replicative Senescence of Atrial Fibroblasts Through Promotion of H3K27me3 in the Promoter Regions of CDKN2a and Timp4 Genes
por: Li, Yingze, et al.
Publicado: (2022)

Girdin acts as an oncogene in gastric cancer by regulating AKT/GSK3β/β-catenin signaling
por: Wang, Yun, et al.
Publicado: (2023)

Nuclear GSK-3β and Oncogenic KRas Lead to the Retention of Pancreatic Ductal Progenitor Cells Phenotypically Similar to Those Seen in IPMN
por: Ding, Li, et al.
Publicado: (2022)

14-3-3σ Regulates β-Catenin-Mediated Mouse Embryonic Stem Cell Proliferation by Sequestering GSK-3β
por: Chang, Tzu-Ching, et al.
Publicado: (2012)

GSK-126 Protects CA1 Neurons from H3K27me3-Mediated Apoptosis in Cerebral Ischemia
por: Wang, Zhongcheng, et al.
Publicado: (2022)

Protein kinase A-mediated Phosphorylation Regulates STAT3 Activation and Oncogenic EZH2 Activity
por: Özeş, Ali R., et al.
Publicado: (2018)

LINC00114 stimulates growth and glycolysis of esophageal cancer cells by recruiting EZH2 to enhance H3K27me3 of DLC1
por: Qin, Jianzhang, et al.
Publicado: (2022)

MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2
por: Zhang, Yi, et al.
Publicado: (2015)

Transcriptome and H3K27 tri-methylation profiling of Ezh2-deficient lung epithelium
por: Holik, Aliaksei Z., et al.
Publicado: (2015)

Anti-helminthic niclosamide inhibits Ras-driven oncogenic transformation via activation of GSK-3
por: Ahn, Sung Yong, et al.
Publicado: (2017)

Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis
por: Jiang, Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0nlrer7ouuqi58pbqrk0r23vec